一种使用医院和药物数据库监测类风湿性关节炎患病率的新方法
Louise Koller-Smith1,2, Ahmed Mehdi1,3, Lyn March2
1Frazer Institute, The University of Queensland, Translational Research Institute (TRI), Level 7, 37 Kent St, Woolloongabba, QLD, 4102, Australia.
Arthritis research & therapy
|July 16, 2024
概括
这项研究开发了一种使用行政数据估计类风湿性关节炎 (RA) 患病率的新算法,证实了自我报告高估了病例. 这种方法为人口研究和健康规划提供了更准确的方法.
科学领域:
- 风湿病学和流行病学
- 医疗保健服务研究 医疗服务研究
- 在医疗保健中的数据科学.
背景情况:
- 目前的风湿性关节炎 (RA) 患病率估计,包括澳大利亚官方数据,严重依赖于自我报告,这已知会高估疾病发病率.
- 由于成本和时间的限制,个人医疗记录审查,即"黄金标准",对于大规模研究和人口监测是不切实际的.
研究的目的:
- 开发和验证一个算法来估计RA病例使用澳大利亚的行政卫生数据.
- 提供一个更准确的,非自我报告为基础的方法,用于RA流行率估计和人口监测.
主要方法:
- 链接来自澳大利亚妇女健康纵向研究 (ALSWH) 的调查数据与国家药物,医院,急诊部 (ED) 和医疗保险福利索赔数据.
- 使用自我报告的疾病,自我报告的药物,分发的药物和医院/ED表现计算的RA患病率.
- 排除了具有混杂自身免疫性疾病的个体,以改进流行率估计.
主要成果:
- 自报的RA患病率为3.9%,而药物数据库定义为1.9%,自报的药物定义在排除后为0.5%.
- 在仅依赖于自我报告的数据时,确认了对RA患病率的显著高估.
- 医院/ED介绍显示,排除后,RA的流行率为0.5%.
结论:
- 已经开发了一个使用行政数据识别RA病例的准确和实用的算法.
- 这个算法可以调整为国际使用,促进人口研究和RA监测.
- 该方法通过利用可访问的输入数据来支持医疗服务规划.
更多相关视频
相关概念视频
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...